Clinical Trial Update: Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Atezolizumab with Bevacizumab in combination with transarterial chemoembolization for patients with BCLC B hepatocellular carcinoma w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Yale University | Conditions: Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-01-15